Company intelligence / Profile preview
Yuyao Biotech
Shanghai, Shanghai, Chinayuyaobiotech.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
Yuyao Biotech is a Shanghai-based biotech company founded in April 2020 that leverages artificial intelligence and modern drug discovery technologies to address major unmet needs in oncology and immune-related diseases. Its lead program YY001 is a small molecule antagonist of the prostaglandin E2 EP4 receptor currently in Phase 2 trials for stomach/gastric cancer as well as other solid tumors. The company has additional programs targeting STAT3 for hematological malignancies and other innovative targets; it collaborates with top academic institutions for translational research. Early clinical data show positive safety/tolerability results for YY001 with ongoing evaluation of efficacy endpoints.
- Therapeutic areas
- OncologyImmunologyNeurologyHematology
- Modalities
- Small moleculeMonoclonal antibodyMonoclonal antibody-drug conjugateGene-modified cell therapyFusion proteinCell therapyOncolytic virus therapySubunit vaccine
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Collaborations with top domestic Chinese academic/research institutions
Beyond the preview
Go deeper on Yuyao Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yuyao Biotech.